Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. [Business Insider]
Revolution Medicines, Inc. (RVMD)
Company Research
Source: Business Insider
Have an account? Log in Healthcare stocks have outperformed the technology sector since September. The Tema Oncology ETF is one fund that has had enjoyed a big rally, up 41% this year. David Song, the fund's manager, highlighted three stock picks for Business Insider. If someone were to ask you which sector has led the market over the last three months, you might guess technology. After all, AI is the only thing you seem to hear about when it comes to stocks these days. You'd be wrong, though — healthcare has actually outperformed every other sector since the start of September as investors have started to look to more defensive assets. The State Street Health Care Select Sector SPDR ETF (XLV) has risen 13% over that period, followed by tech and utilities at 9% and 5%, respectively. One fund that has seen a significant boost during the latest stretch of outperformance is the Tema Oncology ETF ( CANC ), which has risen 28% since September. Year-to-date, the fund is up 41%.
Show less
Read more
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.MarketBeat
- Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.MarketBeat
- Hot Picks: Cancer-focused biotech firms gain attention as key clinical results near [BNN Bloomberg (Canada)]BNN Bloomberg
- Revolution Medicines, Inc. (RVMD) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]Seeking Alpha
- Revolution Medicines (RVMD): Assessing Valuation After Recent 28% Monthly Share Price Surge [Yahoo! Finance]Yahoo! Finance
RVMD
Earnings
- 11/5/25 - Miss
RVMD
Sec Filings
- 11/26/25 - Form 4
- 11/26/25 - Form 4
- 11/25/25 - Form 144
- RVMD's page on the SEC website